#Systemic Lupus Erythematosu (SLE) with Multi-Organ Involvement

[datamerisit]

Effective treatment for autoimmune diseases in ayurveda

Autoimmune diseases are increasingly becoming a global health concern. These conditions occur when the body's own immune system, meant to defend against harmful invaders like bacteria and viruses, mistakenly attacks its own healthy tissues. This leads to chronic inflammation, tissue damage, and dysfunction of vital organs and systems. Common autoimmune disorders include rheumatoid arthritis, lupus, psoriasis, multiple sclerosis, and inflammatory bowel disease. Conventional treatments often provide symptomatic relief but do not resolve the root cause of the problem. Here is where the holistic approach of Ayurveda stands apart.

Ayurveda, India’s ancient and time-tested science of natural healing, offers a profound and effective approach to managing and healing autoimmune diseases. The treatment for autoimmune disease in Ayurveda focuses not only on relieving symptoms but also on correcting the underlying imbalance that leads to the disease. In this article, we explore how Ayurveda approaches autoimmune disorders and why it can be a game-changing option for those suffering from these chronic conditions.

Understanding Autoimmune Diseases from an Ayurvedic Perspective

In Ayurveda, autoimmune diseases are understood as a result of the imbalance of the three doshas—Vata, Pitta, and Kapha—along with the accumulation of Ama (toxins) in the body. When the digestive fire (Agni) is weak due to improper diet, irregular lifestyle, stress, or other factors, the body produces Ama. This sticky, toxic substance spreads through the body, eventually lodging in tissues and joints, disrupting normal functions and leading to disease.

In autoimmune conditions, the accumulation of Ama and the derangement of the doshas cause the body’s defense mechanisms (Ojas or immunity) to fail, making the immune system attack its own tissues. This explains the chronic inflammation, pain, and fatigue seen in many autoimmune diseases. Therefore, the Ayurvedic approach focuses on strengthening digestion, removing Ama, balancing the doshas, and enhancing Ojas to restore the body's natural healing capability.

Common Autoimmune Conditions Treated in Ayurveda

Ayurveda has proven beneficial in managing various autoimmune diseases such as:

Rheumatoid Arthritis (Amavata) An inflammatory joint disorder caused by excessive Ama and aggravated Vata dosha. Symptoms include joint pain, swelling, stiffness, and fatigue.

Psoriasis and Psoriatic Arthritis Skin and joint autoimmune conditions associated with disturbed Pitta and Kapha doshas along with toxin accumulation, resulting in scaly patches and joint discomfort.

Systemic Lupus Erythematosus (SLE) A multi-system disorder where detoxification and immunity enhancement are crucial in Ayurvedic management to reduce systemic inflammation.

Ulcerative Colitis and Crohn’s Disease Inflammatory bowel diseases that require balancing Pitta and Vata doshas while healing the gut lining and enhancing digestive fire.

The Ayurvedic Treatment Approach for Autoimmune Diseases

Deepana & Pachana (Stimulating Digestion) The first stage of the treatment for autoimmune disease in Ayurveda involves correcting the impaired Agni or digestive fire. Herbal preparations and dietary measures are used to improve digestion and prevent the further formation of Ama.

Shodhana (Detoxification Therapies) Once digestion is restored, the next step is the elimination of existing Ama through Panchakarma therapies. These include:

Vamana (emesis) for Kapha disorders

Virechana (purgation) for Pitta imbalance

Basti (medicated enema) for Vata-related conditions

Nasya (nasal therapy) and Raktamokshana (bloodletting) for specific cases

These procedures detoxify the body’s internal systems and remove deeply embedded toxins from the tissues.

Shamana (Pacification) Post-detox, the aggravated doshas are pacified using herbal medicines that reduce inflammation, restore metabolic balance, and nourish the tissues. These formulations are customized based on the patient’s constitution and disease severity.

Rasayana Chikitsa (Rejuvenation) Rejuvenation therapies help rebuild Ojas and strengthen immunity. Rasayana herbs, nourishing diets, yoga, and stress-reduction techniques such as meditation are introduced to improve vitality, mental calmness, and disease resistance.

Ahara & Vihara (Diet and Lifestyle) Long-term management of autoimmune diseases requires personalized dietary and lifestyle changes. Ayurveda recommends warm, light, and freshly prepared foods that are easy to digest while avoiding incompatible and processed foods. Regular sleep patterns, light exercise like yoga, and breathing exercises (pranayama) are also vital components.

Benefits of Ayurvedic Treatment for Autoimmune Diseases

Root-cause healing instead of symptomatic management

Detoxification of body tissues and elimination of harmful Ama

Restoration of digestive strength and immunity (Ojas)

Personalised care tailored to each patient’s dosha and disease type

Minimal to no side effects compared to conventional immunosuppressive drugs

Focus on holistic well-being including physical, mental, and emotional health

Why Dheemahi Ayurveda for Autoimmune Disease Treatment?

At Dheemahi Ayurveda, we specialize in providing the most authentic and effective treatment for autoimmune disease in Ayurveda. Our expert team of qualified Ayurvedic physicians offers:

Detailed consultations based on Ayurvedic principles

Customized Panchakarma detoxification programs

Specially prepared herbal formulations from high-quality sources

Personal dietary and lifestyle guidance for lasting wellness

Post-treatment follow-ups to ensure sustained health benefits

We are committed to helping patients naturally overcome the challenges of autoimmune diseases by addressing their root causes and empowering them with knowledge and tools for lifelong health.

Conclusion

Autoimmune diseases are complex and require an integrative and thoughtful approach. The treatment for autoimmune disease in Ayurveda offers hope beyond temporary symptom suppression. By eliminating toxins, balancing the body's energies, and rejuvenating immunity, Ayurveda helps restore health from within.

If you or your loved ones are struggling with an autoimmune disorder, consider exploring the time-tested wisdom of Ayurveda at Dheemahi Ayurveda. Our customized programs are designed to bring lasting relief and vitality to those seeking natural healing.

Meta Title: Effective Treatment for Autoimmune Diseases in Ayurveda | Dheemahi Ayurveda Meta Description: Discover holistic, natural Ayurvedic treatments for autoimmune diseases. Explore personalized detox, rejuvenation, and immunity-boosting therapies at Dheemahi Ayurveda.

[drashishbadika]

Systemic Lupus Erythematosus (SLE) with Multi-Organ Involvement - Dr. Ashish Badika

Systemic Lupus Erythematosus (SLE) affects different vital organs of the body like the Kidneys, Brain, heart, skin, liver, blood system, and many more.

Lupus in Kidney: SLE in the kidney is called Lupus Nephritis. It causes kidney disease and may get worse with time. It will lead to kidney failure. Half of the patients suffering from Lupus are diagnosed with kidney disease at some or other time during the course of the disease.

Brain: Also called as Neuropsychiatric lupus. People suffering from it have problems like seizures, headaches, memory loss, psychiatric problems, etc.

Heart: Lupus can affect various layers of the heart. Patients may have symptoms of shortness of breath, chest pain, etc. It can lead to heart attacks also.

Get more information related to SLE with Multi-Organ Involvement,

and contact on 6261824727

[biomedres]

Journals on Biomedical Science - BJSTR Journal

Ethnicity Variation in the Treatment of Pediatric Lupus Nephritis by Zhang Aihua in Biomedical Journal of Scientific & Technical Research https://biomedres.us/fulltexts/BJSTR.MS.ID.002062.php Systemic lupus erythematosus (SLE) is known as a complex autoimmune disorder which is characterized by chronic systemic inflammation resulting from antibodies directed against self-antigens, immunity dysfunction and immune complex formation affecting multi-organ system. Lupus nephritis (LN) is a serious component of SLE in which 40-80% are diagnosed in childhood and exerts adverse impact on long-term renal and patient survival. African-Americans (AA), Hispanics, Asians, and non-Caucasians are high-risk populations with higher prevalence and severe disease. Despite the similarities in adults, childhood-onset LN tends to have more active onset and severe disease activity requiring timely recognition and proper treatment. Over the past 2 decades, huge progress has been made in the treatment of childhood LN. Ethnicity has a quite well-defined effect on the response to treatment for which special considerations must be taken in treatment strategy. This review will discuss the current therapies of LN in clinical practice and shows a comparison of treatment responses in different ethnicities. About 10% to 20% of SLE cases are diagnosed during childhood which uses 18 years as the upper cutoff age in most of the studies [1]. The kidney involvement i.e. lupus nephritis (LN) is a serious component of SLE which presents with proteinuria, microscopic hematuria and renal dysfunction thereby exerting adverse impact on long-term renal and patient survival. Up to 40 to 80% of SLE children will develop LN during their disease course. The incidence rates per 100,000 Medicaid-Enrolled children per year for LN was estimated to be higher in Asians (2.08), African-Americans (AA) (0.87) and Hispanics (0.85) as compared with Whites (0.30) [2]. In the same study, prevalence rates per 100,000 children per year are higher among Asians (11.21), AA (5.79), Hispanics (4.30) as compared with Whites (1.19). LN in children, in contrast to adult-onset, have earlier and more aggressive disease activity with high prevalence and relatively poor response to treatment which leads to poor quality of life [3-5]. Fore more articles on Journals on Biomedical Science please click here bjstr Follow on Twitter : https://twitter.com/Biomedres01 Follow on Blogger : https://biomedres01.blogspot.com/ Like Our Pins On : https://www.pinterest.com/biomedres/

[symbiosisonlinepublishing]

Systemic lupus erythematosus (SLE) is a multi-system autoimmune disease characterized by involvement of all organs in the body. The clinical features of the disease are heterogeneous and run in a remitting-relapsing course with variable prognosis.

[sandlerresearch]

Systemic Lupus Erythematosus and Lupus Nephritis: Epidemiology Forecast to 2028 published on

https://www.sandlerresearch.org/systemic-lupus-erythematosus-and-lupus-nephritis-epidemiology-forecast-to-2028.html

Systemic Lupus Erythematosus and Lupus Nephritis: Epidemiology Forecast to 2028

Systemic Lupus Erythematosus and Lupus Nephritis: Epidemiology Forecast to 2028

Summary

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease of multifactorial origin that can affect any organ or organ system, resulting in a broad spectrum of clinical manifestations ranging from dermatological involvement to multi-organ failure with episodes of relapses and remissions. Because of its dynamic nature, this disease has an unpredictable natural course leading to high rates of morbidity and even death (Bertsias, Cervera and Boumpas, 2012; Bhattacharya et al., 2011). Lupus nephritis (LN) or lupus glomerulonephritis is a complication of SLE in which the kidneys are affected. LN is a major contributor to morbidity and mortality among SLE patients (Bhattacharya et al., 2011; O’Neill and Cervera, 2010).

GlobalData epidemiologists utilized historical data obtained from peer-reviewed articles and reports to build the forecast for the diagnosed incident cases and the diagnosed prevalent cases of SLE and LN in the 7MM. GlobalData epidemiologists applied the incidence and prevalence of SLE and LN drawn from the above sources to each country’s population to calculate the number of estimated diagnosed incident cases and diagnosed prevalent cases for SLE and LN.

The following data describes the epidemiology of SLE and LN. In the 7MM, GlobalData epidemiologists forecast an increase in the diagnosed prevalent cases of SLE from 571,021 cases in 2018 to 600,663 cases in 2028, at an Annual Growth Rate (AGR) of 0.52%. When examining the AGR of diagnosed prevalence of SLE in individual markets, GlobalData epidemiologists forecast that the UK will see the highest AGR of 0.79% during the forecast period, while Germany will show the lowest negative AGR of 0.12%. In 2018, the 7MM had 98,620 diagnosed prevalent cases of LN, expected to increase to 102,939 diagnosed prevalent cases by 2028, at an AGR of 0.44%.

Scope

– The Systemic Lupus Erythematosus and Lupus Nephritis Epidemiology Report provides an overview of the risk factors and global trends of Systemic Lupus Erythematosus (SLE) and Lupus Nephritis (LN) in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan). – This report includes a 10-year epidemiological forecast of the diagnosed incident and diagnosed prevalent cases of SLE segmented by age, and sex, and the diagnosed prevalent cases are further segmented by severity. – The report also includes a 10-year epidemiological forecast for various comorbidities of SLE. An epidemiological forecast of the diagnosed incident and diagnosed prevalent cases of LN among pediatric population and adult population for the 7MM is also incorporated. – Additionally, the report includes the diagnosed prevalent cases of LN segmented by World Health Organization (WHO) and International Society of Nephrology (ISN)/Renal Pathology Society (RPS) classification into Classes I-VI. – The SLE and LN epidemiology report is written and developed by Masters- and PhD-level epidemiologists. – The Epidemiology Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 7MM. – The Epidemiology report is easy to navigate, interactive with dashboards, and epidemiology-based with transparent and consistent methodologies. Moreover, the report supports data presented in the report and showcases disease trends over a 10-year forecast period using reputable sources.

Reasons to buy

The SLE and LN Epidemiology series will allow you to – – Develop business strategies by understanding the trends shaping and driving the global SLE and LN markets. – Quantify patient populations in the global SLE and LN markets to improve product design, pricing, and launch plans. – Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for SLE and LN therapeutics in each of the markets covered. – Understand magnitude of SLE and LN population by its severity.

[jeffreyrwelch]

Autoimmune Disease in Dogs — Four Main Causes and Treatment Plans

The post Autoimmune Disease in Dogs — Four Main Causes and Treatment Plans by Arden Moore appeared first on Dogster. Copying over entire articles infringes on copyright laws. You may not be aware of it, but all of these articles were assigned, contracted and paid for, so they aren’t considered public domain. However, we appreciate that you like the article and would love it if you continued sharing just the first paragraph of an article, then linking out to the rest of the piece on Dogster.com.

One night when Carol Bryant prepared to brush the teeth of her Cocker Spaniel, she discovered bleeding and splotchy-colored gums. Scared and worried, she immediately took Dexter to the nearest veterinary emergency room. At the animal hospital, veterinarians confirmed the diagnosis: an autoimmune disease called Immune-Mediated Thrombocytopenia (IMT) that attacks the blood-clotting platelets.

“My veterinarians told me that had I waited until the morning, Dexter would have bled out internally,” says Carol, of Forty Fort, Pennsylvania. “IMT is a silent killer. You have to act fast or it could cost your dog his life.” IMT belongs to the autoimmune disease family headlined by lupus, hypothyroidism and immune-mediated hemolytic anemia (IMHA). In various ways, autoimmune disease in dogs causes the body’s immune system to attack its tissues and organs. Some forms wipe out red blood cells and platelets.

“Autoimmune diseases are more common than people realize and can be difficult to identify and challenging to treat,” says Robert Runde, VMD, a veterinary internal medicine specialist who treated Dexter at the North East Referral Animal Hospital in Wilkes-Barre, Pennsylvania. “And often a dog with one autoimmune disease may have multiple other immune-mediated conditions.”

Four main causes of autoimmune disease in dogs

Certain breeds are at risk for autoimmune disease in dogs. Photography ©Teran Buckner | Phido Photography.

Genetics, disease-carrying ticks, sulfa antibiotic medications and vaccine reactions are among identified culprits that can trigger autoimmune disease in dogs. Veterinarians do not know why, but breeds like Cocker Spaniels, German Shepherd Dogs, Poodles, Collies, Beagles, Irish Setters, Afghan Hounds, Doberman Pinschers and Old English Sheepdogs are most at risk.

Ticks are also blamed, but it can be tricky to definitely identify a disease-borne tick for triggering an autoimmune disease in a dog, because it can take weeks, even months, to surface. “That’s why it is always important to thoroughly check a dog from head to tail, especially behind his ears and between his toes for ticks after taking hikes,” Dr. Runde says. “Your dog should be on a tick preventive. I’ve seen dogs acting normal one day and the next day not able to walk because of a tick-borne disease.”

Antibiotics known as sulfa drugs can also trigger autoimmune reactions in some dogs. These medications are prescribed to treat bacterial, respiratory and urinary infections as well as bowel inflammation and types of gastrointestinal conditions. “Because sulfa drugs can be a culprit, I don’t use them unless absolutely necessary,” Dr. Runde says.

Controversy surrounds another possible cause behind the emergence of autoimmune diseases in dogs — vaccination booster injections. “Vaccines stimulate the immune system, and if a dog has an autoimmune disease, the vaccines can adversely stimulate the dog’s immune system,” Dr. Runde says. “Once we know a dog has an immune-mediated disease, it is best to keep vaccines to a minimum or to stop them. Instead, the dog can get titer tested.”

Titer testing involves a veterinarian drawing a blood sample from a dog and checking it for levels of antibodies to protect against canine diseases, including parvovirus, distemper, rabies and adenovirus.

Kathryn Primm, DVM, owner and chief veterinarian at Applebrook Animal Hospital in Ooltewah, Tennessee, adds, “Vaccine protocols are no longer a ‘one size fits all’ plan. It is critical that pet owners work with their own veterinarians to decide which vaccines are most appropriate for their pets.”

Tricks to identify autoimmune disease in dogs

Acting like detectives, veterinarians must often seek detailed medical histories, analyze blood and urine samples, take biopsy samples and perform X-rays, ultrasounds and MRIs (magnetic resonance imaging) to determine if the dog has an autoimmune disease — or was reacting to eating swallowed pennies or an infection or perhaps an obstruction in his intestinal tract.

“Identifying and managing autoimmune diseases is an involved process, and if you skip one of the steps, you could miss something important,” Dr. Runde says.

Dr. Runde has also seen Dexter’s canine nephew named Sonny, whose pet parent is Jen Angradi, of Duryea, Pennsylvania. During the summer, Jen noticed that her usually calm dog was panting excessively on the sofa. She then lifted his muzzle to discover that his gums were nearly completely white. She rushed him to the animal hospital.

“Sonny spent three days at the animal hospital,” Jen says. “The first couple days were tough. I felt like I was on an emotional roller coaster ride. They treated Sonny, and now he is on prednisone as well as a medication to prevent blood clots, and folic acid to promote healthy red blood cells. He is doing much better now.”

Canine lupus

Ironically, one of the best-known autoimmune diseases in people is also one of the rarest in dogs — lupus. The two types of canine lupus are systemic lupus erythematosus (SLE) and discoid lupus erythematosus (DLE).

SLE can strike any part of the body. Common symptoms displayed are fever, hair loss, lameness, muscle stiffness, and sores or lesions. In contrast, DLE affects a dog’s skin, particularly around the nose and thus has earned the nickname, “Collie nose.” Dogs with DLE display ulcers, sores or crusty skin. Sadly, there is no cure for either type of lupus.

Treatment plans are customized for an individual dog’s symptoms. Common treatments include the use of steroids, antibiotics, omega-3 fatty acids and even chemotherapy. “There aren’t that many cases of lupus in dogs,” Dr. Runde says. “In dogs, lupus can cause multi-organ failure.” With autoimmune diseases, relapses can and do occur. You can help your dog by ensuring he gets regular and thorough health examinations and reporting any changes in his activity level or physical condition to your veterinarian promptly.

A great health ally for veterinarians like Dr. Runde is the professional dog groomer. “Often a person will take his dog to the groomers and, after shaving the dog, the groomer will notice perhaps bruised skin, bleeding gums or bloody diarrhea,” he says. “We’ve treated many dogs for autoimmune diseases detected by groomers.”

Treatment plans for autoimmune disease in dogs

Genetics, disease-carrying ticks, sulfa antibiotic medications and vaccine reactions are among culprits that can trigger autoimmune disease in dogs. Photography ©anyaberkut | Getty Images.

Treatment plans must be tailored to the specific needs of each dog dealing with an autoimmune disease. “Immune-mediated diseases are challenging, and dog owners should understand that it is a lifelong issue that is managed and not cured, but that does not mean there is no hope,” Dr. Primm says. “Following the veterinarian’s advice and care plan plus being an engaged caregiver can make all the difference.”

Carol and Jen vow to pay close attention to their dogs Dexter and Sonny and to report any health changes at the onset. “When Dexter arrived at the hospital, he had no platelets, but he was still wagging his tail. He was given essentially a canine cocktail of immune suppressants that saved his life,” says Carol, who pens a popular pet blog called Fidose Of Reality.

“My message to others is to know what’s normal in your dog. Take 10 minutes a day to really check your dog, including the gums. If you find anything wrong, act fast. You just may save your dog’s life.

Facebook support groups for autoimmune disease in dogs

More pet parents, veterinarians and pet professionals are sharing information about autoimmune disease in dogs through social media. Here is a sampling of some Facebook support groups for people dealing with autoimmune disease in dogs:

Canine Lupus – Canine Lupus Support & Info/Find a Cure: facebook.com/CanineLupusSupportAndInfoFindACure

Immune-Mediated Thombocytopenia (IMT) Canine Immune Disorders: facebook.com/groups/ImmMediatedThrombocytopeniaCanineImmuneDisorders

Immune-Mediated Hemolytic Anemia in Dogs (IMHA): facebook.com/groups/6228146980/about

Thumbnail: Photography ©Dean Golja | Getty Images.

Editor’s note: This article first appeared in Dogster magazine. Have you seen the new Dogster print magazine in stores? Or in the waiting room of your vet’s office? Subscribe now to get Dogster magazine delivered straight to you!

About the author

Arden Moore, The Pet Health and Safety Coach, is a pet behavior consultant, master certified pet first aid instructor, author and host of the Oh Behave Show on Pet Life Radio. Learn more at ardenmoore.com.

Read more about dog health and care on Dogster.com:

Cushing’s Disease in Dogs — Signs, Diagnosis and Treatment

What to Know About Inflammatory Bowel Disease in Dogs

Liver Disease in Dogs: Symptoms, Causes and Treatments

The post Autoimmune Disease in Dogs — Four Main Causes and Treatment Plans by Arden Moore appeared first on Dogster. Copying over entire articles infringes on copyright laws. You may not be aware of it, but all of these articles were assigned, contracted and paid for, so they aren’t considered public domain. However, we appreciate that you like the article and would love it if you continued sharing just the first paragraph of an article, then linking out to the rest of the piece on Dogster.com.

[industrymarketresearch2017-blog]

Systemic Lupus Erythematosus (SLE) Epidemiology Forecast to 2025 Risk Factors and Global Trends

Systemic lupus erythematosus (SLE) is a chronic autoimmune disease of multifactorial origin that can affect any organ or organ system, resulting in a broad spectrum of clinical manifestations ranging from dermatological involvement to multi-organ failure with episodes of relapses and remissions.

 Because of its dynamic nature, this disease has an unpredictable natural course leading to high rates of morbidity and even death. The incidence and prevalence of SLE varies globally and the variation is attributed to a combination of elements such as the characteristics of the population studied, sex, ethnicity, geographical locations, occupational factors, familial traits, time of study, and the diagnostic criteria used.

Browse Detail  Market Report With TOC @ http://www.hexareports.com/report/epicast-report-systemic-lupus-erythematosus-sle-epidemiology-forecast-to-2025  

 In 2015, the 7MM had 475,698 diagnosed prevalent cases of SLE, for all ages, men and women combined. The US accounted for approximately 53% of the diagnosed prevalent cases (253,215) in the 7MM. Epidemiologists forecast that there will be 498,420 diagnosed prevalent cases of SLE in the 7MM by 2025, with an Annual Growth Rate (AGR) of 0.48% during the forecast period. The diagnosed prevalent cases of SLE are projected to increase in all markets, except for Germany and Japan, where there were slight decreases during the forecast period.

 The increase in the prevalent cases of SLE in the US and the UK are attributed to a forecast increase in SLE prevalence over time and changes in the underlying population. Epidemiologists held the prevalence constant for the remaining markets; thus any changes observed in the remaining markets are attributed to changes in the population.

 Epidemiologists utilized data from country-specific studies published in peer-reviewed journals and governmental documents to provide the age- and sex-specific prevalence of diagnosed SLE in the respective markets. The forecast methodology was consistent across all of the 7MM to allow for a meaningful comparison among them.

Request A Sample copy of This Report @ http://www.hexareports.com/report/epicast-report-systemic-lupus-erythematosus-sle-epidemiology-forecast-to-2025/request-sample

 Scope of this Report:

·         The Systemic Lupus Erythematosus (SLE) EpiCast Report provides an overview of the risk factors, comorbidities, and global and historical trends of SLE in the seven major markets (7MM) (US, France, Germany, Italy, Spain, UK, and Japan). It includes a 10-year epidemiology forecast of diagnosed prevalent cases of SLE (as per the 1997 revised American College of Rheumatology classification) segmented by sex, age, and severity. This report also provides an epidemiological forecast of the diagnosed prevalent cases of lupus nephritis (LN) among SLE patients for the 7MM, segmented into both 1995 WHO classifications (1985 for Japan) and 2003 ISN/RPS classifications.

·         The SLE epidemiology report is written and developed by Masters- and PhD-level epidemiologists.

·         The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 7MM.

Reasons To Buy

1.      Develop business strategies by understanding the trends shaping and driving the global SLE market.

2.      Quantify patient populations in the global SLE market to improve product design, pricing, and launch plans.

3.      Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for SLE therapeutics in each of the markets covered.

4.      Identify the percentage of diagnosed prevalent cases of SLE by severity.